News

Moleculin Reports First Quarter 2025 Financial Results And Provides Corporate Update
Enrollment and dosing underway in Phase 3 clinical trial (the“MIRACLE” trial) evaluating Annamycin (naxtarubicin) for the treatment of R/R AML </p ...
FDA Upheaval Pushes Some Biotech Firms to Plan Early Trials Out of US
The FDA did not respond to a request for comment. U.S. Health Secretary Robert F. Kennedy Jr. has said that the agency's ...
Upheaval at FDA pushes some biotech firms to move early trials out of US
Some U.S. biotech companies are considering moving early-stage trials of new medicines outside the United States as worry ...
European governments scramble to interpret Trump's new drug pricing order
European governments are examining whether U.S. President Donald Trump can force them to pay more for prescription medicines, ...
Savara Reports First Quarter 2025 Financial Results and Provides a Business Update
Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, ...
Older adults in U.S. urged to skip this travel vaccine. What about Canada?
The United States is advising travellers aged 60 and up to hold off on getting the chikungunya vaccine while it looks into reports of possible side effects.
Aurobindo Pharma arm’s biosimilar gets marketing nod from U.K.’s MHRA
Aurobindo Pharma's CuraTeQ Biologics receives marketing authorization for Zefylti filgrastim biosimilar in the UK and EU.